Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis

被引:469
作者
Zha, JP
Weiler, S
Oh, KJ
Wei, MC
Korsmeyer, SJ [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Dana Farber Canc Inst,Howard Hughes Med Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.1126/science.290.5497.1761
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many apoptotic molecules relocate subcellularly in cells undergoing apoptosis. The pro-apoptotic protein BID underwent posttranslational (rather than classic cotranslational) N-myristoylation when cleavage by caspase 8 caused exposure of a glycine residue. N-myristoylation enabled the targeting of a complex of p7 and myristoylated p15 fragments of BID to artificial membranes bearing the Lipid composition of mitochondria, as well as to intact mitochondria. This post-proteolytic N-myristoylation serves as an activating switch, enhancing BID-induced release of cytochrome c and cell death.
引用
收藏
页码:1761 / 1765
页数:5
相关论文
共 24 条
  • [1] ARDAIL D, 1990, J BIOL CHEM, V265, P18797
  • [2] Blobel G, 1995, COLD SPRING HARB SYM, V60, P1
  • [3] A role for N-myristoylation in protein targeting: NADH-cytochrome b(5) reductase requires myristic acid for association with outer mitochondrial but not ER membranes
    Borgese, N
    Aggujaro, D
    Carrera, P
    Pietrini, G
    Bassetti, M
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 135 (06) : 1501 - 1513
  • [4] Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
    Brunet, A
    Bonni, A
    Zigmond, MJ
    Lin, MZ
    Juo, P
    Hu, LS
    Anderson, MJ
    Arden, KC
    Blenis, J
    Greenberg, ME
    [J]. CELL, 1999, 96 (06) : 857 - 868
  • [5] Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death
    Chen, FL
    Hersh, BM
    Conradt, B
    Zhou, Z
    Riemer, D
    Gruenbaum, Y
    Horvitz, HR
    [J]. SCIENCE, 2000, 287 (5457) : 1485 - 1489
  • [6] Conversion of Bcl-2 to a Bax-like death effector by caspases
    Cheng, EHY
    Kirsch, DG
    Clem, RJ
    Ravi, R
    Kastan, MB
    Bedi, A
    Ueno, K
    Hardwick, JM
    [J]. SCIENCE, 1997, 278 (5345) : 1966 - 1968
  • [7] Solution structure of BID, an intracellular amplifier of apoptotic signaling
    Chou, JJ
    Li, HL
    Salvesen, GS
    Yuan, JY
    Wagner, G
    [J]. CELL, 1999, 96 (05) : 615 - 624
  • [8] A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
    Enari, M
    Sakahira, H
    Yokoyama, H
    Okawa, K
    Iwamatsu, A
    Nagata, S
    [J]. NATURE, 1998, 391 (6662) : 43 - 50
  • [9] REGULATION OF THE MEVALONATE PATHWAY
    GOLDSTEIN, JL
    BROWN, MS
    [J]. NATURE, 1990, 343 (6257) : 425 - 430
  • [10] Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death
    Gross, A
    Yin, XM
    Wang, K
    Wei, MC
    Jockel, J
    Millman, C
    Erdjument-Bromage, H
    Tempst, P
    Korsmeyer, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) : 1156 - 1163